Transarterial chemoembolization combined with lenvatinib and camrelizumab for unresectable hepatocellular carcinoma: A prospective, single-arm, multicenter study. Landmark analysis of OS by response ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results